Raymond Kreiger
Payments from drug & device makers
Across 145 payments — averaging $24.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$434
- Johnson & Johnson$357
- Novartis$316
- Arcutis Biotherapeutics, Inc.$300
- LEO Pharma Inc.$268
- Regeneron Healthcare Solutions, Inc.$259
- plus $2K from 16 others
What the payments were for
- Consulting fees$3008%
- Food & beverage$2,83879%
- Education$44512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $434 |
| Johnson & Johnson(2 entities) | 15 | $357 |
| Novartis | 15 | $316 |
| Arcutis Biotherapeutics, Inc. | 1 | $300 |
| LEO Pharma Inc. | 17 | $268 |
| Regeneron Healthcare Solutions, Inc. | 10 | $259 |
| Incyte Corporation | 6 | $228 |
| Sanofi | 10 | $201 |
| Amgen | 7 | $184 |
| Sanofi-aventis U.S. LLC | 2 | $169 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $142 |
| Biofrontera Inc. | 6 | $116 |
| Sun Pharmaceutical Industries Inc. | 5 | $108 |
| VYNE Pharmaceuticals Inc. | 5 | $106 |
| Botanix SB Inc | 4 | $100 |
| Intercept Pharmaceuticals, Inc. | 3 | $62 |
| Galderma Laboratories, L.p. | 3 | $60 |
| Dermavant Sciences, Inc. | 3 | $57 |
| Merz North America, Inc. | 2 | $41 |
| Pfizer | 2 | $35 |
| Redhill Biopharma Inc. | 1 | $23 |
| Almirall LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORYVE$300
How this compares
$3,583 in reported general payments places this provider in the 90th percentile of 1,544 surgical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 34 | $128,261 |
| Tacrolimus | 11 | $1,739 |
| Clindamycin Phosphate | 29 | $1,395 |
| Triamcinolone Acetonide | 65 | $738 |
| Mometasone Furoate | 31 | $648 |
| Ketoconazole | 45 | $605 |
| Clobetasol Propionate | 18 | $596 |
| CiclopiroxCiclopirox Olamine | 32 | $530 |
| Ammonium Lactate | 14 | $209 |
| Mupirocin | 25 | $161 |
| Hydrocortisone | 11 | $120 |
Paid to pharmacies, not to this prescriber.
Other surgical in Bronx
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Sarah MartineckWilliamsville$87K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Alexandra DemeglioNew York$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.